BNIP3L and malignant colon neoplasm: BNIP3L is a new prognostic biomarker for melanoma patients (Kazimierczak et al., 2020) and is related to the development and metastasis of hepatocellular carcinoma (HCC) and colon cancer (Chen et al., 2020).